Improving Dermatology Clinical Efficiency in Academic Medical Centers

Closing the clinical support perception gap: An opportunity to improve alignment between dermatologists and staff in the academic setting

“…Primary cutaneous amyloidosis has been imaged with RCM, 2 and BCC peritumoral-mucin on RCM has been histopathologically verified. 3 To our knowledge, however, no prior reports have demonstrated BCC-associated amyloid on RCM or OCT, and OCT descriptions of mucin have been inferential. Herein, we report in vivo characterization of amyloid and mucin through RCM-OCT, followed by precise histopathologic correlation.…”

“…2 Investing in staff training, technology, and education has been recommended as a strategy to improve clinical efficiency and empower faculty with tools for success in academic dermatology clinics. 3 We identified a gap between staff and physician perception of clinical support staff (CSS), which is anecdotally very common, and we launched a technology-based pilot training intervention for CSS.…”

Practice Efficiency in Dermatology: Enhancing Quality of Care and Physician Well-Being

“…Results included a 30% increase in completed visits and a 33% increase in gross payments, along with improved faculty satisfaction and less at-home charting time. The additional salary costs were covered in just four months [ 19 ].…”

Assessment of dermatology clinic resources at safety-net hospitals: Results from a national survey

“…For example, the increase from 1 nurse per provider to 2 nurses led to a 30% increase in completed visits at 1 university hospital dermatology clinic. 4 In the outpatient dermatology clinic at Parkland Health and Hospital System in Dallas, Texas, the hiring of an additional nurse resulted in a 31% decrease in wait times. 5 Our survey of safety-net dermatology clinics revealed that they have long wait times for appointment availability, high no-show rates, and are understaffed in regards to medical assistants and nurses.…”

“…To the Editor: Recent reports document successful treatment of alopecia areata (AA) with tofacitinib. [1][2][3][4][5] However, long-term data using tofacitinib monotherapy is still sparse, and we are unaware of the quality of treatment in persons of Asian decent. We report the results of extended tofacitinib monotherapy in adult Korean patients with moderate-to-severe AA.…”